Evan M. Zahn, MD, has joined the Cedars-Sinai Heart Institute in Los Angeles to focus on the study of congenital heart disease and develop more minimally invasive treatments for the program. As director of pediatric cardiology at the Cedars-Sinai Heart Institute and director of its congenital heart disease program, he will diagnose and treat children born with heart defects such as hypoplastic left heart syndrome and tetralogy of Fallot.
Zahn also will be establishing a program aimed at treating adult patients with congenital heart issues.
He joined Cedars-Sinai after serving as chief of cardiology at Miami Children's Hospital. Zahn also directed Miami Children’s interventional catheterization program and performed the world’s first nonsurgical tricuspid valve replacement via catheter on a 9-year-old boy.
Zahn received a bachelor’s degree in biology at the State University of New York at Albany before earning his medical degree from New York Medical College in Valhalla. He completed his pediatric training at the University of Colorado’s Affiliated Hospitals in Denver.